These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37073890)

  • 1. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
    Wang Y; Sun X; Yang Q; Guo C
    Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
    Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
    Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
    Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
    Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3.
    Chen LL; Xia LY; Zhang JP; Wang Y; Chen JY; Guo C; Xu WH
    Phytother Res; 2023 Mar; 37(3):809-819. PubMed ID: 36447385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
    Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
    Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
    Niu M; Song S; Su Z; Wei L; Li L; Pu W; Zhao C; Ding Y; Wang J; Cao W; Gao Q; Wang H
    Br J Pharmacol; 2021 Nov; 178(22):4485-4500. PubMed ID: 34265073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro.
    Ge Z; Liu D; Shang Y; Li Y; Chen SZ
    J Nat Med; 2020 Sep; 74(4):741-749. PubMed ID: 32601830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway.
    Wijaya YT; Setiawan T; Sari IN; Park K; Lee CH; Cho KW; Lee YK; Lim JY; Yoon JK; Lee SH; Kwon HY
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3149-3162. PubMed ID: 36127129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
    Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?
    Jaśkiewicz A; Domoradzki T; Pająk B
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
    White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
    Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
    Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.